Seizure cost-effectiveness of therapy

Jump to navigation Jump to search

Seizure Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Seizure from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electroencephalogram

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Seizure cost-effectiveness of therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Seizure cost-effectiveness of therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Seizure cost-effectiveness of therapy

CDC on Seizure cost-effectiveness of therapy

Seizure cost-effectiveness of therapy in the news

Blogs on Seizure cost-effectiveness of therapy

Directions to Hospitals Treating Seizure

Risk calculators and risk factors for Seizure cost-effectiveness of therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Shakiba Hassanzadeh, MD[2]

Overview

The national economical impact of epilepsy is estimated at $9.6 billion per year in the United States.

Cost-effectiveness of Therapy

The national economical impact of epilepsy is estimated at $9.6 billion per year in the United States.[1]

References

  1. Yoon D, Frick KD, Carr DA, Austin JK (2009). "Economic impact of epilepsy in the United States". Epilepsia. 50 (10): 2186–91. doi:10.1111/j.1528-1167.2009.02159.x. PMID 19508694.